NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹710 Cr | ₹466 Cr | ₹428 Cr | ₹439 Cr | ₹363 Cr |
What is the latest Total Current Liabilities ratio of NEULAND LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹710 Cr |
| Mar2025 | ₹466 Cr |
| Mar2024 | ₹428 Cr |
| Mar2023 | ₹439 Cr |
| Mar2022 | ₹363 Cr |
How is Total Current Liabilities of NEULAND LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹710 Cr | 52.51 | |
| Mar2025 | ₹466 Cr | 8.89 | |
| Mar2024 | ₹428 Cr | -2.57 | |
| Mar2023 | ₹439 Cr | 20.87 | |
| Mar2022 | ₹363 Cr | - | |
Compare Total Current Liabilities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹25,526.8 Cr | -4.5% | -11.5% | 28.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,427.0 Cr | 0.2% | -4.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,982.0 Cr | -3.1% | -1.6% | 47.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,196.0 Cr | -1.2% | -5% | 29.4% | Stock Analytics | |
| CIPLA | ₹107,746.0 Cr | 2.3% | -2% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,894.0 Cr | 2.2% | 6.2% | -2.5% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -4.5% |
-11.5% |
28.6% |
| SENSEX | 3.8% |
-0.6% |
-9.1% |
You may also like the below Video Courses